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vABSTRACT
This research is about the solvent and temperature effect in the polymorphism study
of 2,6-Dihydroxybenzoic Acid (2,6DHB) Crystal. Polymorphism is the ability of substance
to crystallize into different crystal structures. Polymorphism is important, as difference in
physical properties of polymorphs can impact on issues such as solubility, bioavailability,
formulation, patent protection, regulatory compliance and downstream particle handling
such as filtration, drying, milling and compaction. The physical properties of polymorphs
can be affected by variation of solvent and temperature. Currently, the solvent selection for
crystallization is often trial and error procedure (Gu et al., 2004) and polymorphs of 2,6-
DHB from some solvent is still unknown. This study is aimed to provide guideline for
rational choices of solvent with different properties for polymorph screening and as
extension to Adam (2011) research. The selection of solvent in this study were based on the
polarity of 2,6-DHB solute and solvents molecule. Solvent chosen were Benzene Formic
Acid and Diethylamine. Meanwhile, the temperature that is going to be used are 20, 35 and
50 oC. The methodology for this study is gravimetric methods for the crystallization and for
analysis methods, Van’t Hoff equation, XRD, DSC, TGA and optical microscope are going
to be used. But due to time limitations only optical microscope analysis method is used.
Different type of solvent at specific temperatures have a significant effect in polymorphism
of 2,6-DHB crystal and its physical properties. Based on the study, the rank of 2,6-DHB
solubility in different solvents are Diethylamine>Formic Acid>Ideal>Benzene. Low solute-
solvent interactions and poor solubility was observed in Benzene. The polymorphic
characterization analysis has concluded that a Form 1 (plate-like) crystal was observed in
Formic Acid and Diethylamine and the crystals are transforming to Form 2(needle-like)
based on observation. Form 2(needle-like) was observed in Benzene due to prolonged time
to achieve supersaturation and limitations of analysis.
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ABSTRAK
Kajian ini adalah berkenaan mempelajari kesan pelarut dan suhu dalam kajian
polimorfisme bagi kristal Asid 2,6-Dihydroxybenzoic (2,6-DHB) . Polimorfisme ialah
keupayaan sesuatu sebatian organik untuk menghablur ke dalam struktur kristal yang
berbeza. Polimorfisme adalah penting kerana perbezaan sifat fizikal yang terdapat pada
setiap kristal mempunyai kesan terhadap kebolehlarutan, kebolehan formulasi,
perlindungan paten dan pematuhan piawaian. Ia juga memberi kesan kepada proses
pengendalian bahan seperti penapisan, pengilangan, pengeringan dan pemadatan. Sifat-sifat
fizikal polimorf boleh dipengaruhi oleh perubahan suhu dan jenis pelarut. Pada masa
sekarang, tiada proses tetap yang digunakan untuk memilih pelarut untuk pengkristalan 2,6-
DHB,sebaliknya hanya kaedah cuba jaya yang digunakan (Gu et al., 2004). Polimorf 2,6-
DHB dari beberapa jenis pelarut juga masih belum diketahui. Kajian ini ialah bertujuan
untuk menyediakan garis panduam bagi pemilihan pelarut secara rasional dan sebagai
sambungan kepada kajian Adam (2011). Pemilihan pelarut di dalam kajian ini ialah
berdasarkan kekutuban molekul bahan larut 2,6-DHB dan pelarut Pelarut yang digunakan
ialah Benzene, Asid Formik dan Diethylamine. Metodologi bagi kajian ini ialah dengan
menggunakan kaedah gravimetrik untuk pengkristalan dan kaedah analysis yang digunakan
ialah persamaan Van’t Hoff, mikroskop optik, XRD, DSC dan TGA. Tetapi oleh kerana
batasan masa, hanya alat mikroskop optik yang berjaya digunakan. Kelainan jenis pelarut
dan suhu ternyata memberi kesan terhadap struktur kristal yang terhasil dan sifat-sifat
fizikalnya. Berdasarkan kajian, aras kebolehlarutan yang berjaya diketahui ialah
Diethylamine> Asid Formik> Ideal> Benzene. Interaksi antara bahan larut-pelarut yang
telah diperhatikan ialah rendah di dalam Benzene dan kebolehlarutan Benzene juga rendah.
Kesimpulan daripada pencirian struktur polimorf menggunakan mikroskop optik mendapati
bahawa Kristal Bentuk 1 (seperti plat) diperhatikan didalam Diethylamine dan Asid Formik
dan kristal ini sedang berubah bentuk ke Bentuk 2(seperti jarum). Bentuk 2 (sepeti jarum)
telah diperhatikan di dalam Benzene dan hal ini mungkin disebabkan oleh masa yang
panjang untuk larutan mencapai tahap tepu dan batasan-batasan yang terdapat dalam kajian.
CHAPTER 1
INTRODUCTION
1.1 Introduction
This chapter comprises the background of study. A brief introduction about the
study will be described. Later, the problem statement, research objectives and scope of
study will be emphasized. This chapter also addressed the significance or rationale of the
study.
1.2 Background Of Study
2,6-Dihydroxybenzoic Acid (2,6-DHB) is a white crystalline powder and has been
evaluated as an active pharmaceutical ingredients (API). In pharmaceuticals, it is used in
the treating of tumors and commonly employed as reagent in the synthesis of
pharmaceutical materials especially antipyretic, analgesic and anti-rheumatism agents
(Adam et al., 2011).
Majority of active pharmaceutical ingredients (APIs) including 2,6-DHB are
produced in solid forms or crystal forms. They are frequently delivered to the patient in the
solid state as part of an approved dosage form such as in the form of tablets or capsules.
Solids dosage form provides a convenient, compact and generally stable format to store an
API. 2,6-DHB can exhibit polymorphism in crystalline form.
21.2.1 What is Polymorphism ?
Polymorphism is the ability of a solid material to exist in more than one form or
crystal structure. It is estimated about 80-90% of organic compounds can exhibit
polymorphism (Stahly, 2007). Different polymorphs of a compound are chemically
identical which same molecular structure but exhibit different physical properties.
Polymorphs are known to present significant differences in the physicochemical properties
such melting point, density, morphology, solubility and colour. As a result, it may have an
impact on the stability (physical and chemical), bioavailability and processability during
manufacturing and/or in the final product (Heinz et al., 2009). The different crystalline
forms showed by one substance may result from a variation in crystallization temperature
or difference of solvent (Sangwal, 2009; Mullin, 2001; Tung, 2009).
1.2.2 Why Polymorphism Study is Important?
In term of pharmaceuticals, polymorphism study is important because majority of
Active Pharmaceutical Ingredients (APIs) are produced in crystal forms and can exhibit
polymorphism. Severe consequences of drug products might happen due to the
inconsistencies in the solid phase produced during the manufacturing and storage of drug
substance. The approximate shape of crystals or crystal morphology can affect downstream
particle handling such as filtration, drying, milling and compaction (Chen and Trout, 2010).
It is also an important attribute of powdered materials that affects the ease with which a
pharmaceutical formulation can be pressed into a tablet (Mirza et al., 2009).
Llinas and Goodman (2008) said that more recently, the polymorphism study of
drugs has been the subject of strong interest in the pharmaceutical industry. In particular,
the variation in solubility between different polymorphs is important, as it can affect drug
efficacy, bioavailability and more importantly safety of the final product. They also said
that new polymorphs can still appear without notice because polymorphs can transform
spontaneously from less stable to more stable forms, and the most stable polymorph will be
the least soluble.
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most stable form, ideally while a drug candidate is still in the discovery phase, so that the
form will be the one used for subsequent testing. Polymorphs test is regulatory requirement
for new chemicals for Food and Drug Administration (FDA) to ensure that the final product
is safe. It is also significant for intellectual property considerations because crystal forms
with superior properties can be protected by patents (Chawla and Bansal, 2003).
1.3 Problem Statement
2,6-Dihydroxybenzoic Acid(2,6-DHB) can exist in three different crystalline forms
which are Form I(metastable), Form II(stable) and monohydrate which shows different
physical properties (Adam, 2011). The physical properties of polymorphs can be affected
by variation of solvent and temperature. Currently, the solvent selection for crystallization
is often trial and error procedure (Gu et al., 2004) and solubility data for some solvents are
not available in the literature. In fact, polymorphs of 2,6-DHB from some solvent is still
unknown. These problems have result to this proposed research.
1.4 Research Objectives
1.4.1 To establish the solubility function of 2,6-DHB acid polymorphs in a specific
solvent type at different temperatures.
1.4.2 To identify and characterize the effect of different solvents towards polymorphic
forms of 2,6-DHB.
1.5 Scope of Study
1.5.1 Selection of solvent is based on the polarity of solvent molecules and 2,6-DHB
solute molecules. The solvents are Benzene, Formic Acid and Diethylamine.
1.5.2 Gravimetric method is used to study the solubility of 2,6-DHB at 20, 35 and 50oC.
1.5.3 Solubility is determined by using Van’t Hoff equation.
41.5.4 Polymorphic form of 2,6-DHB is going to be characterized by using optical
mic4roscope, XRD, DSC and TGA.
1.6 Rationale/Significance of Study
The type of solvent is the key factor in polymorphic selectivity and crystal
morphology. It is important understand the polymorphism of 2,6-DHB by the effect of
solvent type and temperature. Research conducted by Adam (2011) has proved that 2/3 of
2,6-DHB crystals from different solvent exhibit polymorph. Hence, this study is aimed to
provide guideline for rational choices of solvent with different properties for polymorph
screening and extension to Adam (2011) research. This research also will provide
information about the polymorphs and may lead to further research.
CHAPTER 2
LITERATURE REVIEW
2.1 Introduction
This chapter comprises of the literature from fundamental theory to previous study
findings.  It started with crystallization and polymorphism theory, and later followed by
previous findings for solubility and polymorphic forms of 2,6-DHB.
2.2 Crystallization
Crystallization is a physical or chemical process or action which results in the
formation of regularly-shaped, -sized, and -patterned solid forms known as crystals. It is
concerned with the development from solution or melt of the crystalline state (Blagden et
al., 2007). In pharmaceutical industry, crystallization is significant as a separation process
for intermediates and often serves as the final step in the manufacture of active
pharmaceutical ingredients (API).
2.3 Kinetics of Crystallization Process
Crystallisation is a process of molecular aggregation in a solution, leading to the
formation of nuclei and, later, crystal growth and eventually creating a crystalline phase.
Supersaturation, nucleation and crystal growth are the major physical phenomena
associated with crystallization (Banga et al., 2004).
62.3.1 Supersaturation
Supersaturation is defined as the concentration of the solute in excess of saturated
concentration under given conditions of temperature (Banga et al., 2004). The number of
potential solid forms which are thermodynamically accessible depends on the level of
supersaturation. This is because different solid forms have different solubility (Chen et al.,
2011). Supersaturation is the driving force of the crystallization; hence the rate of
nucleation and growth is driven by the existing supersaturation in the solution (Tung,
2009). It is composed of two zones; the metastable and unstable zones (see Figure 2.1
below). The two zones are defined so that the metastable region shows crystals growing
without nucleating, whereas in the unstable region crystals appear after nucleation.
Figure 2.1 Concentration of solute during crystallization
Source: Bange et al. (2004)
72.3.2 Nucleation
Nucleation is a molecular assembly process, where a critical number of molecules
are needed to achieve the phase change from solution into a crystal or solid (Blagden et al.,
2007). The nuclei are stable only when they achieve a critical size and the critical size is
governed by parameters such as supersaturation and temperature (Chen and Trout, 2010).
2.3.3 Crystal Growth
Crystal growth will take place after nucleation is achieved and it will lead to the
growth of embryonic crystals into a larger size and shape. Crystal lattice of the molecular
solids and the effects of solvent selection and additives on the process of crystal growth are
three key drivers that related with regard to the shape of growing crystals (Blagden et al.,
2007). The process of crystal growth to into visible size involves at least two stages: (1)
formation of stable 3D nuclei and (2) development of stable 3D nuclei into crystals with
well-developed faces (Sangwal, 2007).
2.4 Polymorphism
In pharmaceuticals, polymorphism is often described as the ability of a drug
substance to exist as two or more crystalline phases that have different arrangement and/or
conformation of the molecules in the crystal lattice (Yu et al., 2003).
According to International Conference on Harmonization (ICH) Guideline Q6A,
polymorphism is defined to include polymorphs, solvate, and amorphous form as shown in
Figure 2.2. Amorphous solids or known as solid that lacks of the long-range order of a
crystal consist of disordered arrangements of molecules and do not hold a distinguishable
crystal lattice. Crystal forms that contain either stoichiometric or nonstoichiometric
amounts of solvent are called solvates. Solvates are commonly known as hydrates when the
incorporated solvent is water.
8Figure 2.2 Polymorphism of a chemical compound
Source: Yu et al. (2003)
Different polymorphs of a solid substance are chemically identical but will exhibit
different physical properties and behaviour, such as different solubility and melting points.
The different crystalline forms showed by one substance may result from a variation in
crystallization temperature or difference of solvent (Mullin, 2001; Tung, 2009). Crystal
polymorph sometimes undergo transformation without a change of external form, the result
being an aggregate of very small crystals of the stable modification confined within
boundaries of the original unstable form (Mullin, 2001).
92.5 Physical Properties of Polymorphs
As mentioned before, different polymorphs of a compound are chemically identical
which same molecular structure but exhibit different physical properties.
2.5.1 Solubility
Solubility is defined as the equilibrium (maximum) amount of solute that can be
dissolved in a specific solvent system (Tung, 2009). According to (Yu et al., 2003)
polymorphs in pharmaceuticals may have different aqueous solubility and dissolution rates.
When the differences are big between, the bioavailability maybe adjusted it will be difficult
to formulate a bioequivalent drug product using a different polymorph. Aqeuous solubility
of a drug is usually determined using the equilibrium solubility method which involves
suspending an excess amount of a solid medicine in a selected aqueous medium.
Solubility correlates to the strength of solvent-solute interactions which are
influenced by solvent properties such as hydrogen bond acceptor or donor propensity,
polarity/dipolarity, dipole moment, dielectric constant, viscosity, surface tension and
cohesive energy (Gu et al., 2004).
The solubility reflects a strong solute-solute interactions exist in the solvents which
solubility is lower then ideal solubility and strong solute solvent interaction when solubility
is higher than ideal solubility (Adam, 2011). The solubility can be obtained by using Van’t
Hoff Plot.
2.5.2 Enthalpy and Entropy of Dissolution
Dissolution in crystallization can be explained as the breakdown of the crystal
lattice into individual ions, atoms or molecules and their transport into the solvent. ΔHdiss
can be defined as a process of solute going into solution and it represents the energy
required for the solute molecules to overcome the intermolecular forces in the solution
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(Adam, 2011). Meanwhile, Entropy of Dissolution ΔSdiss is the disorder of the system for
dissolution process.
2.5.3 Stability of Polymorphs
In pharmaceuticals, the most stable polymorphic form of a medicine substance is
often used in a formulation because it has the lowest potential for conversion from one
polymorphic form to another (Yu et al., 2003). On the contrary, metastable (less stable
form) or even amorphous might be chosen to enhance the bioavailability of medicine
product. One polymorph may convert to another during process or storage, particularly
when a metastable form. Gibbs free energy, thermodynamics activity and solubility provide
the definitive measures of relative polymorphic stability under defined conditions of
temperature and pressure.
2.6 Crystal Morphology
Crystal morphology is the appearance or approximate shape of crystals. It is also
called crystal habit (Tung, 2009). Although crystal can be classified into seven general
systems, the relative sizes of the face of particular crystal can differ considerably.
Crystals may grow rapidly, or be stunted, in one direction; thus an elongated growth
of the prismatic habit gives a needle-shaped crystal (acicular habit) and a stunted growth
gives a flat plate-like crystal (tabular, platy or flaky habit). Ostwald’s Step Rule suggests
that in general, the least stable polymorph will crystallize first instead of most stable
polymorph (Threlfall, 2003).
Crystallization from solutions of a substance in different solvents generally results
in change habit. The degree of supersaturation of a solution often exerts a significant
influence on the crystal habit, and so can the state agitation of the system (Mullin, 2001).
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2.7 2,6-Dihydroxybenzoic Acid Solute
2,6-DHB is categorized under carboxylic acid group which OH can act as a proton
donor and C=O can act as the proton acceptor in forming hydrogen bond either between the
solute itself or the solvent. 2,6-DHB Acid is a polar compound.
Figure 2.3Molecular structure of 2,6-DHB
2.7.1 Solubility of 2,6-Dihydroxybenzoic Acid
Adam (2011) has conducted polymorphism study for 15 types of solvent and they
found that low solubility for 2,6-DHB Acid in toluene and xylene isomers which are o, p,
m-xylene solvents which indicate strong solvent-solvent interaction and weak solvent-
solute interaction exist in the system. Cyclohexane and hexane was found to be low
solubility or poor solute-solvent interaction to accelerate the dissolution process because of
they have the highest value of heat of compared to other solvents studied in that research.
The results in Adam et al. study found that the rank of solubility of 2,6-DHB in solvents are
methanol > ethanol > IPA > EA > acetonitrile > acetone > IPE > diethylether > tert-butyl
methyl ether > IDEAL > chloroform > toluene > o-xylene > m-xylene > p-xylene > hexane
> cyclohexane. The ideal solubility of 2,6-DHB is obtained from Davey et al. (2001) study.
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Figure 2.4 Ideal solubility data for 2,6-DHB
Source: Davey et al. (2001)
According to Grant and Haguchi (1990), at a specific temperature, the polymorphic
form with higher activity will also have higher solubility and lower stability. This has been
proved in Adam et. Al study that polymorph of Form I(metastable) which is grown from
toluene at 20oC, m-,p-,o-xylene at 35, and 50oC which have lower melting point from the
DSC measurements and plate-like shape show the difference in activities and escaping
tendencies. Davey et al. (2001) show that as the temperature increase, the solubility of 2,6-
DHB in specific solvents also increase.
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2.7.2 Polymorphic Forms of 2,6-Dihydroxybenzoic Acid
The first crystal structure of this material was found in 1994 by Gdaniac et al. who
obtained crystals from chloroform solution. 2,6-DHB can exist in three types of
polymorphic forms. Form I is metastable, Form II is stable and monohydrates (Chen and
Trout, 2010; Adam et. al, 2011b).
Davey et al. (2001) found that 2,6-DHB Acid crystallize as Form I from toluene
and exhibit plate-like crystals. In chloroform, 2,6-DHB Acid crystallize as Form II and
exhibit needle-like crystals.
Chen and Trout (2010) found that crystallization of 2,6-DHB in single solvents such
as ethanol, toluene, chloroform exhibit thin needle like crystal while in mixture of toluene
and diethylether the aspect ratio of needle-like crystals is increased.
Adam (2011) in their study found that Form I and Form II crystal shape were
obtained as platelike and needle like respectively. They also conclude that solvents
crystallize the Form II (stable) at all temperatures except in o-xylene, p-xylene and m-
xylene and toluene which crystallize metastable Form I.
2.8 Function of Solvents in Crystallization
Industrial Solvents Handbook defines solvent as a substance in which another
substance is dissolved forming a solution. It is used to suspend or modify the physical
properties of a material. Many organic liquids can act as solvents it is use as ingredients in
the production of various products. Some solvents selectively favor the crystallization of a
particular form or forms. In addition, by varying the solvent, it will affect crystal
morphology, crystallization kinetics, formulation and drug stability (Tung, 2009).
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2.8.1 Solvents Selection
An important consideration when choosing a solvent for crystallization is the solute
to be crystallized should be readily soluble in the solvent and it should be easily deposited
from the solution in the desired crystalline form after cooling, evaporation, etc. Solvents
can be classified as being polar or non-polar; the earlier description given to liquids which
have high dielectric constants (e.g. water, acids, alcohols, and the latter refers to liquid of
low dielectric constant (e.g. aromatic hydrocarbons).
Based on the nature of intermolecular bonding interactions, solvents can be divided
into three main classes which are 1) polar protic; 2) dipolar aprotic; 3) non-polar aprotic. In
polar protic solvents, the solvent molecules interact by forming strong hydrogen bonds. In
order to dissolve, the solute must break these bonds and replace them with bonds of similar
strength. Dipolar aprotic solvents are characterized by high dielectric constants, the solvent
molecules interact by dipole-dipole interactions. If the solute is also dipolar and aprotic, it
can interact readily with the solvent molecules forming similar dipole-dipole interactions.
In non-polar aprotic solvents (low dielectric constants), molecules interact by weak Van
Der Waals forces (Mullin, 2001).
In this research, there are three types of solvents chosen which are Benzene, Formic
Acid and Diethylamine. Below is the summary table for some of the properties of these
solvents.
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Table 2.1 The solvent properties considered in solvent selection for the polymorph
screening
Solvent Type MolecularStructure
Boiling Point
(oC)
Dipole
Moment
Polar/Non-
Polar
Benzene 101 0.00 Non-polar
Formic Acid 80.1 1.41 Polar
Diethylamine 55.5 0.92 Polar
Source: Gu et al. (2004)
CHAPTER 3
RESEARCH METHODOLOGY
3.1 Introduction
This chapter comprises of methodology for experimental work and analysis for
this study. It emphasizes on material and properties needed for this study, experimental
work and analysis method.
3.2 Materials and Properties
2,6-DHB (C7H6O4) is a white crystalline powders with 98% purity. There are
three types of solvents that are going to be used which are Formic Acid, Benzene and
Diethylamine. All this materials were obtained from Sigma Aldrich.
3.3 Experimental Work
In this research, Gravimetric Method was used in order to obtain polymorphs
from the crystallization of 2,6-DHB Acid with the three type of solvents at different
temperatures.
The saturated solution is prepared by dissolving a certain amount of 2,6-DHB
Acid powder into 5-25 mL solvent until excess solute is observed. After saturation is
achieved, the solution is shaken using Thermomixer with speed at 400 rpm and the time
is according to temperature shown below.
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Table 3.1 Shaking time for saturated solution at specific temperature
Temperature(oC) Time (hours)
20 12
35 8
50 5
Figure 3.1 Thermomixer
The solution is left for about one hour after shaking at the specific temperature
until the supernatant forms. The solution is then filtered using 0.45µm membrane filter
and left in the vacuum oven for drying. Finally, the polymorphs are characterized using
optical microscope, XRD, DSC and TGA.
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Figure 3.2 Vacuum oven
3.4 Solubility and Solvation Study
The solubility can be calculated using the equation below (Adam, 2011).
= , (3.1)
The Van’t Hoff Plot is plotted by using the equation as expressed below. The slope from
the Van’t Hoff Plot is Δ / while the y-intercept is Δ .
ln( ) = + (3.2)
3.5 Characterization of Polymorphs
In order to determine and characterize the polymorphs, these three analysis
techniques are going to be used which are optical microscopy, XRD, DSC and TGA.
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These analysis techniques are the most frequently used in polymorphs characterization
(Chieng et al., 2011).
3.5.1 Optical Microscopy
Optical microscope is used for crystal habit imaging of polymorph formed
(Adam, 2011) Microscopy characterizes polymorphs through the optical and
morphology properties of crystal and it can reveal possible difference in crystal habit
(Yu et al., 2003).
Figure 3.3 Optical microscope
3.5.2 X-Ray Diffraction
X-ray Diffraction (XRD) is used to directly detect crystal lattice properties.
Changes in the diffraction pattern can imply the existence of a new polymorph
(appearance or disappearance of polymorph-specific diffraction peaks), or a smaller
change in the crystal lattice, such as the introduction of a slight disorder or change in
lattice parameters (small decreases in peak intensity or minor peak shifts) (Chieng et al.,
2011).
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When a 2-D diffraction pattern is recorded, it shows concentric rings of
scattering peaks corresponding to the various d-spacing in the crystalline lattice. The
positions and the intensities of the peaks can be used for identifying the underlying
structure (or phase) of a solid material. For example, the diffraction lines of diamond
would be different from graphite even though they both are made of carbon atoms. This
phase identification is important because the material properties are highly dependent on
the structure.
3.5.3 Thermal Gravimetry Analysis and Differential Scanning Calorimetry
TGA and DSC is used to differentiate polymorphs on the basis of the phase
transitions they undergo during heating and can be used to obtain additional information
regarding these phase transitions including melting, desolvation, crystallization, and
glass transition.
These thermal methodologies can also be used to determine the relative stability
among polymorphs and to differentiate enantiotropic and monotropic systems. For an
enantiotropic system, the relative stability of a pair of solid forms inverts at some
transition temperature beneath the melting point, whereas in a monotropic system, a
single form is always more stable beneath the melting point (Yu et al., 2003).
DSC determines polymorphism samples by monitoring the thermal events during
heating while TGA measures any changes in the weight of specimen while varying
temperature in a controlled nitrogen atmosphere (Adam, 2011).
CHAPTER 4
RESULT & DISCUSSION
4.1 Introduction
In this chapter, the solubility of 2,6-DHB in specific solvent will be discussed.
The solubility function of 2,6-DHB is established and discussed using Van’t Hoff Plot.
Besides, the characterization of 2,6-DHB solid crystals which crystallized from three
different solvents are discussed using optical microscopy to check the crystal habit.
4.2 Solubility of 2,6-Dihydroxybenzoic Acid
In the experiment, a certain weight amount of 2,6-DHB solute  was dissolved in
7 mL of each type of solvent. The solute is added into the solvent solution until excess
solute is observed in the glass vial. At this point, once there is no any solute dissolve in
the solvent, it signifies that the solution is achieving the saturation point. Saturation also
indicates that the solute concentration in the solution is at its solubility limit (Tung,
2009). Hence, the solubility function is established by plotting the Van’t Hoff Plot as
discussed in Section 3.4.
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Table 4.1Weight of 2,6-DHB dissolved in three different types of solvent
Temperature(oC) Mass of 2,6-DHB Dissolved (g)Benzene Formic Acid Diethylamine
20 0.0053 0.7159 1.3339
35 0.0089 1.1285 1.6183
50 0.0288 1.8790 1.7416
In Section 2.8.1 (Table 2.1), the molecular geometry of each solvent shows that
benzene is nonpolar solvent meanwhile formic acid and diethylamine is polar. The
solubility is calculated using equation 3.1 in Section 3.3. In Table 4.2, the solubility at
saturation is recorded at 20oC, 35oC and 50oC and the solubility is calculated in mol/mol.
Table 4.2 Solubility data of 2,6-DHB in three different solvent(mol/mol)
Temperature (oC) Molsolute/MolsolventBenzene Formic Acid Diethylamine
20 0.0004 0.0250 0.1278
35 0.0007 0.0395 0.1551
50 0.0024 0.0657 0.1669
Figure 4.1 shows the solubility trend of 2,6-DHB in different solvent at increase
temperature. It was obvious that as the temperature increase, the solubility of 2,6-DHB
also increase. Among all the solvent, Benzene has the lowest solubility and small
solubility increase as a function of temperature.
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Figure 4.1 Graph of solubility versus temperature for 2,6-DHB in three different solvent
As from the literature (Section 2.5.1), solubility correlates to the strength of
solvent-solute interactions which are influenced by solvent properties such as hydrogen
bond acceptor or donor propensity, polarity/dipolarity, dipole moment, dielectric
constant, viscosity, surface tension and cohesive energy (Gu et. al, 2004). In order, to
determine the strength of solvent-solute interactions, Van’t Hoff Plot is referred to
compare the solubility to the ideal solubility. The Van’t Hoff equation is referred to
Equation 3.2 in Section 3.4.
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